|
Jun 27
|
Sanofi reports positive data from Phase III EoE treatment trial
|
|
Jun 26
|
Dupixent® (dupilumab) Positive Phase 3 Data in Children 1 to 11 Years of Age with Eosinophilic Esophagitis Published in the New England Journal of Medicine
|
|
Jun 26
|
Press Release: Dupixent positive phase 3 data in children one to 11 years of age with eosinophilic esophagitis published in NEJM
|
|
Jun 26
|
Sanofi reports data from Phase II demyelinating polyneuropathy trial
|
|
Jun 26
|
Sanofi Seeks Initial Offers for Its $20 Billion Consumer Arm
|
|
Jun 26
|
Pharma M&A: The top high value deals in 2023
|
|
Jun 25
|
Press Release: Availability of the Q2 2024 Aide-mémoire
|
|
Jun 25
|
Novavax (NVAX) Seeks Nod for Updated COVID-19 Jab in Europe
|
|
Jun 21
|
Sanofi and Biovac partner to produce polio vaccines in Africa
|
|
Jun 21
|
Press Release: Audrey Duval Derveloy appointed Global Head of Corporate Affairs, member of Sanofi’s Executive Committee
|
|
Jun 21
|
Press Release: ISTH: Sanofi advances leadership in hemophilia with new data for ALTUVIIIO and fitusiran
|
|
Jun 20
|
Regeneron (NASDAQ:REGN): Is This Stock-Split Contender a Strong Buy?
|
|
Jun 20
|
Press Release: Sanofi and Biovac spearhead polio vaccine manufacturing capabilities in Africa
|
|
Jun 18
|
Sanofi and Belharra forge $700m partnership for immunological diseases
|
|
Jun 18
|
Sanofi taps Belharra for immune drug research; AstraZeneca’s new cancer drug falls short
|
|
Jun 14
|
Is It Too Late to Buy Novavax Stock?
|
|
Jun 13
|
Why It's A New Day For COPD Patients — And Regeneron, Sanofi, Verona Stocks
|
|
Jun 13
|
Exploring Three Top Dividend Stocks On Euronext Paris
|
|
Jun 12
|
Sanofi: Information concerning the total number of voting rights and shares – May 2024
|
|
Jun 12
|
A Life Expansion Revolution Is Coming: 3 Stocks That Could Lead the Charge
|